Pharmaceutical group · United States
Elanco
A group of 15 companies with 183 medicines in 3 countries.
Group structure
15 companies in 6 countries
Loading…
Pharmaceutical group · United States
A group of 15 companies with 183 medicines in 3 countries.
15 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 183
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADVANTAGE MULTI 1040 mg / 0.4 ml + 10 mg / 0.4 ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ADVANTAGE MULTI 100400 mg / 4.0 ml + 100 mg / 4.0 ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ADVANTAGE MULTI 1880 mg / 0.8 ml + 8 mg / 0.8 ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ADVANTAGE MULTI 20100 mg / ml + 25 mg / ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ADVANTAGE MULTI 55250 mg / 2.5 ml + 62.5 mg / 2.5 ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ADVANTAGE MULTI 940 mg / 0.4 ml + 4 mg / 0.4 ml · Solution | Imidacloprid, Moxidectin | Canada | Marketed | 2005 |
| ATOPICA25 mg · Capsule | Ciclosporin | Canada | Marketed | 2007 |
| ATOPICA100 mg · Capsule | Ciclosporin | Canada | Marketed | 2007 |
| ATOPICA10 mg · Capsule | Ciclosporin | Canada | Marketed | 2007 |
| ATOPICA50 mg · Capsule | Ciclosporin | Canada | Marketed | 2007 |
| ATOPICA FOR CATS100 mg / ml · Solution | Ciclosporin | Canada | Marketed | 2012 |
| BAYCOX50 mg / ml · Suspension | Toltrazuril | Canada | Marketed | 2010 |
| BAYTRIL150 mg · Tablet | Enrofloxacin | Canada | Marketed | 1999 |
| BAYTRIL22.7 mg · Tablet | Enrofloxacin | Canada | Not marketed | 1997 |
| BAYTRIL68 mg · Tablet | Enrofloxacin | Canada | Not marketed | 1997 |
| BAYTRIL50 mg · Tablet | Enrofloxacin | Canada | Marketed | 1999 |
| BAYTRIL15 mg · Tablet | Enrofloxacin | Canada | Marketed | 1999 |
| BAYTRIL 100100 mg / ml · Solution | Enrofloxacin | Canada | Marketed | 2004 |
| BAYTRIL INJECTION50 mg / ml · Solution | Enrofloxacin | Canada | Marketed | 1997 |
| BAYTRIL OTIC5 mg / ml + 10 mg / ml · Emulsion | Enrofloxacin, Silver sulfadiazine | Canada | Marketed | 2002 |
| BEXACAT15 mg · Tablet | Bexagliflozin | Canada | Marketed | 2026 |
| CAPSTAR57 mg · Tablet | Nitenpyram | Canada | Marketed | 2001 |
| CAPSTAR11.4 mg · Tablet | Nitenpyram | Canada | Marketed | 2001 |
| CLARO16.6 mg / ml + 2.2 mg / ml + 14.8 mg / ml · Solution | Florfenicol, Mometasone, Terbinafine | Canada | Marketed | 2019 |
| CLINACOX 0.5%5 G / Kg · Drug Premix | Diclazuril | Canada | Not marketed | 2003 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 170 | 128 | 42 | CompaniesAll medicines |
| Brazil | 10 | 0 | 10 | CompaniesAll medicines |
| European Union (EMA) | 3 | 0 | 3 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licence: Licence Ouverte / Open Licence
Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Keep Elanco’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.